Authors Paradigm Shift Platforms
Breaking down the “efficacy” and safety of the #COVID19 vaccines if applied to the population
https://t.co/q8sXpkVxjs
PFIZER VACCINE
— Paradigm Shift Platforms (@Shift_Platforms) January 26, 2021
Rate...
Relative measure of effect (incidence rate ratio):
(8 cases/2,214 person-years) / (162 cases/2,222 person-years)
= 0.05
or a 95% less rate of occurrence of #COVID19 cases for vaccine vs. placebo pic.twitter.com/Qg1Em914Cv
https://t.co/tYCGHKgzqW
MODERNA VACCINE
— Paradigm Shift Platforms (@Shift_Platforms) January 26, 2021
Only RISK- (& not rate-) related measures are provided for Moderna...
Relative measure of effect (incidence risk ratio):
(11 cases/14,134 persons) / (185 cases/14,073 persons)
= 0.06
or a 94% less risk of occurrence of #COVID19 cases for vaccine vs. placebo pic.twitter.com/xiZPi6QXH8
https://t.co/mQicBLheTJ
ASTRAZENECA VACCINE
— Paradigm Shift Platforms (@Shift_Platforms) January 26, 2021
Rate...
Relative measure of effect (incidence rate ratio):
(44.1 cases/1,000 person-years) / (149.2 cases/1,000 person-years)
= 0.296
or a 70.4% less rate of occurrence of #COVID19 cases for vaccine vs. placebo pic.twitter.com/OJD6xeOksq
Pfizer vaccine summary:
^ Are those 0.13% less #COVID19 cases worth the development of an expected 20.7% or 1,614,000,000 related adverse events (of which 1,443,042 would be serious) over a week (and completely unknown magnitude of related adverse events beyond this first week)?https://t.co/w6VSAuFZcg pic.twitter.com/Cl1hVx5XT0
— Paradigm Shift Platforms (@Shift_Platforms) January 26, 2021